<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Rodriguez CL | Mattioli Lab</title><link>https://mattioli-lab.org/author/rodriguez-cl/</link><atom:link href="https://mattioli-lab.org/author/rodriguez-cl/index.xml" rel="self" type="application/rss+xml"/><description>Rodriguez CL</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Tue, 01 Oct 2024 00:00:00 +0000</lastBuildDate><image><url>https://mattioli-lab.org/media/icon_hu4816693337678208890.png</url><title>Rodriguez CL</title><link>https://mattioli-lab.org/author/rodriguez-cl/</link></image><item><title>AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution</title><link>https://mattioli-lab.org/publication/akt-ezh2-tnbc/</link><pubDate>Tue, 01 Oct 2024 00:00:00 +0000</pubDate><guid>https://mattioli-lab.org/publication/akt-ezh2-tnbc/</guid><description/></item><item><title>Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers</title><link>https://mattioli-lab.org/publication/epigenetic-oncogenic-crc/</link><pubDate>Thu, 01 Aug 2024 00:00:00 +0000</pubDate><guid>https://mattioli-lab.org/publication/epigenetic-oncogenic-crc/</guid><description/></item><item><title>Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC</title><link>https://mattioli-lab.org/publication/ezh2-hdac-prostate/</link><pubDate>Sat, 01 Apr 2023 00:00:00 +0000</pubDate><guid>https://mattioli-lab.org/publication/ezh2-hdac-prostate/</guid><description/></item></channel></rss>